Pathios Therapeutics Logo Pathios Therapeutics Logo
    • About Us
    • Science
    • Our Team
    • The Board
    • Investors
    • News
    • Contact Us

Latest News & Updates

Pathios Highlights Role of GPR65 as Innate Immune Checkpoint in Tumor Microenvironment at AACR 2022

Pathios Highlights Role of GPR65 as Innate Immune Checkpoint in Tumor Microenvironment at AACR 2022

Human ex vivo data demonstrates the promise of Pathios’ ‘Macrophage Conditioning’ approach in reversing the immunosuppressive polarization of macrophages brought about by an acidic microenvironment.
Read More
Pathios presents preclinical in vivo data for small molecule GPR65 inhibitor in PDX cancer model

Pathios presents preclinical in vivo data for small molecule GPR65 inhibitor in PDX cancer model

Data highlights the ability of GPR65 inhibition to bring about a robust Type I/II interferon (IFN) gene signature and reduce tumor burden in a renal cell carcinoma (RCC) PDX model.
Read More
Pathios Therapeutics boosted by award of significant Innovate UK funding

Pathios Therapeutics boosted by award of significant Innovate UK funding

Pathios has been awarded £350K (approximately US$475K) in the form a Smart Grant from Innovate UK, the UK Government’s innovation agency, to accelerate their cancer immunotherapy programme targeting the innate...
Read More
Pathios announces appointment of Dr. Tobias Bopp as the foundational member of its SAB

Pathios announces appointment of Dr. Tobias Bopp as the foundational member of its SAB

Pathios has appointed Dr. Tobias Bopp, a leading academic and pioneer in the study of the influence of acidosis on tumour immunology, as the foundational member of its Scientific Advisory...
Read More
Endpoints news reports: ‘Canaan backs Pathios’ search for small molecule drugs that hit ‘orphan’ GPCR

Endpoints news reports: ‘Canaan backs Pathios’ search for small molecule drugs that hit ‘orphan’ GPCR

Pathios Therapeutics in the news.
Read More
Pathios closes US$8.8M Series A and appoints Stuart Hughes as CEO to accelerate the development of our first-in-class therapies.

Pathios closes US$8.8M Series A and appoints Stuart Hughes as CEO to accelerate the development of our first-in-class therapies.

Pathios has announced a US$8.8M Series A financing round with leading international healthcare investors Canaan and Australia’s Medical Research Commercialisation Fund managed by Brandon Capital (“MRCF”).
Read More
FierceBiotech reports: ‘Sygnature backs Pathios in hunt for GPR65 modulators’.

FierceBiotech reports: ‘Sygnature backs Pathios in hunt for GPR65 modulators’.

Pathios Therapeutics in the news.
Read More
Partnership Forms for First-in-Class Therapies for Autoimmune Diseases and Immuno-Oncology

Partnership Forms for First-in-Class Therapies for Autoimmune Diseases and Immuno-Oncology

Pathios Therapeutics in the news
Read More
« Previous 1 2 3 Next »
Pathios Therapeutics Logo
  • About Us
  • Science
  • Our Team
  • The Board
  • Investors
  • News
  • Contact Us
  • LinkedIn
  • Cookie Policy
  • Privacy Policy
  • © Copyright 2025 | Pathios Therapeutics Ltd | Registered in England & Wales | Company No. 10641754
We use cookies to give you the best experience of our site and for us to understand how our site is used. Click on “I accept” below if you are happy for us to use cookies. Click on “I do not accept” below if you would like to browse the site without cookies, other than those that are strictly necessary to make our site work.
Reject AllAccept All
Cookie Settings
For more detailed information about the cookies we use and how to change or disable them see our Read More.
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
_GRECAPTCHA6 monthsGoogle reCAPTCHA sets a necessary cookie (_GRECAPTCHA) when executed for the purpose of providing its risk analysis.
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie records the user consent for the cookies in the "Advertisement" category.
cookielawinfo-checkbox-analytics1 yearThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional1 yearThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary1 yearThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others1 yearThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance1 yearThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
rc::asessionThis cookie is set by the Google recaptcha service to identify bots to protect the website against malicious spam attacks.
rc::bsessionThis cookie is set by the Google recaptcha service to identify bots to protect the website against malicious spam attacks.
rc::csessionThis cookie is set by the Google recaptcha service to identify bots to protect the website against malicious spam attacks.
rc::fsessionThis cookie is set by the Google recaptcha service to identify bots to protect the website against malicious spam attacks.
viewed_cookie_policy1 yearThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
wordpress_[hash] (Admin only)sessionUsed to store the authentication details on login. The authentication details include the username and double hashed copy of the password. However, this usage of the cookie is limited to the admin console area, the backend dashboard of the website.
wordpress_logged_in_XXXsessionWordPress uses this cookie to indicate when you’re logged in, and who you are, for most interface use.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
-settings-1, wp-settings-time-11 yearWordPress uses this cookie to customize your view of admin interface, and possibly also the main site interface.
VISITOR_INFO1_LIVE6 monthsYouTube sets this cookie to measure bandwidth, determining whether the user gets the new or old player interface.
VISITOR_PRIVACY_METADATA6 monthsThis cookie is used to store the user's consent and privacy choices for their interaction with the site. It records data on the visitor's consent regarding various privacy policies and settings, ensuring that their preferences are honored in future sessions.
YSC6 monthsThis cookie is set by YouTube to track views of embedded videos.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga1 year 1 month 4 daysGoogle Analytics sets this cookie to calculate visitor, session and campaign data and track site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognise unique visitors.
_ga_*1 year 1 month 4 daysGoogle Analytics sets this cookie to store and count page views.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
CookieDurationDescription
cerber_groove cerber_groove_x_#14 daysProtect the website from hackers, cyber criminals, spammers
SAVE & ACCEPT